WORCESTER, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology (“ACT”; OTCBB: ACTC) announced today that William M. Caldwell, IV, the company’s Chairman and CEO, will present at the Fifth Annual World Stem Cells & Regenerative Medicine Congress to be held May 11 -- 13 in London, UK. The World Stem Cells & Regenerative Medicine Congress is a three-day event that showcases the work of some of the world’s most innovative scientists and executives involved in commercial stem cell research.
Mr. Caldwell’s talk, entitled “Moving towards the clinic: future outlook on generating revenue from hESC-based products”, will be given at 10:10 a.m. local time (5:10 am EDT) on Thursday, May 13. The presentation will address the commercial outlook on the regenerative medicine industry from the perspective of human embryonic stem cell (hESC) use, and strategies for an industry-wide effort to bring hESCs to the market. More information about the presentation can be found at http://www.terrapinn.com/2010/stemcells/SPK-william-CALDWELL.stm.
Mr. Caldwell will also present at the Sixth Annual Rodman & Renshaw Global Healthcare Conference, May 16 – 18 in London, on Tuesday, May 18 at 3:40 p.m. local time (10:40 a.m. EDT). More information on this conference can be found at http://www.rodmanandrenshaw.com/conferences.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-K for the year ended December 31, 2009.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
CONTACT:
Investors:
CEOcast, Inc. for Advanced Cell
Dan Schustack, 212-732-4300
or
Press:
Gotham Communications, LLC
Bill Douglass, 646-450-3615
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Health Biotechnology Other Health
MEDIA: